The MRN (Mre11-Rad50-Nbs1)-ATM (ataxia-telangiectasia mutated) pathway is essential for sensing and signaling from DNA double-strand breaks. The MRN complex acts as a DNA damage sensor, maintains genome stability during DNA replication, promotes homology-dependent DNA repair and activates ATM. MRN is essential for cell viability, which has limited functional studies of the complex. Small-molecule inhibitors of MRN could circumvent this experimental limitation and could also be used as cellular radio-and chemosensitization compounds. Using cell-free systems that recapitulate faithfully the MRN-ATM signaling pathway, we designed a forward chemical genetic screen to identify inhibitors of the pathway, and we isolated Z-5-(4-hydroxybenzylidene)-2-imino-1,3-thiazolidin-4-one (mirin, 1) as an inhibitor of MRN. Mirin prevents MRN-dependent activation of ATM without affecting ATM protein kinase activity, and it inhibits Mre11-associated exonuclease activity. Consistent with its ability to target the MRN complex, mirin abolishes the G2/M checkpoint and homology-dependent repair in mammalian cells.The cellular response to DNA damage coordinates DNA repair with cell cycle progression and/or apoptosis. This response is essential to maintain the integrity of the genome. Defects in the DNA damage response can lead to genomic instability, a mutagenic condition leading to cancer predisposition 1,2 . Inherited mutations in the ATM, MRE11A and NBN genes are responsible for the cancer-prone syndromes ataxia-telangiectasia, ataxia telangiectasia-like disorder and Nijmegen breakage syndrome (NBS), respectively. These syndromes share clinical and cellular phenotypes including hypersensitivity to ionizing radiation (IR), radioresistant DNA synthesis, checkpoint deficiencies and chromosomal instability.